济民药业,关爱无限 www.pidrug.com
香港济民药业微信二维码
198 9654 1773
当前位置:首页 > 药品资讯 > 精神科 > 布斯帕BusPIRone

布斯帕BusPIRone

[ 人气:160 | 日期: 2020-08-04 | 返回 | 打印 ]
布斯帕BusPIRone
药品名称:布斯帕BusPIRone
药品别名:盐酸布斯帕、布司必隆、布斯哌隆、丁螺环酮、Buspar
英 文 名:BusPIRone
药品价格:$ 美国市场售价 33.35 美元
研发公司:
适 用 症:适用于泛发性焦虑症的治疗,对各种身心症状有良好的疗效
型号规格:5mg/10mg/15mg/30mg多种型号,每瓶100片装
药品详情:

【布斯帕BusPIRone 简述】
 
    布斯帕BusPIRone别名盐酸布斯帕、布司必隆、布斯哌隆、丁螺环酮、Buspar,是一类神经系统抗焦虑药物。

布斯帕BusPIRone_香港济民药业

布斯帕BusPIRone_香港济民药业

布斯帕BusPIRone_香港济民药业


 
 
【布斯帕BusPIRone 适应症】
 
    布斯帕BusPIRone适用于泛发性焦虑症的治疗,对各种身心症状有良好的疗效。 
 
【布斯帕BusPIRone 规格】
 
    本品为片剂,分为5mg/10mg/15mg/30mg多种型号,每瓶100片装;    
 
【布斯帕BusPIRone 服用方法】
 
1.开始时每次5mg,每天2~3次,以后根据病情和耐受情况调整用量,每隔2~3天加5mg,可增至每天20~30mg,至达到预期的疗效。每天最高口服剂量不超过60mg。
 
2.老人使用本药应从小剂量开始,一般不超过15mg/天。 
 
【布斯帕BusPIRone 注意事项】
 
1.老年人应减量。
 
2.应监测患者焦虑的减轻程度。
 
3.服药期间禁止饮酒。
 
4.用药期间不宜驾驶车辆和操作机械。
 
5.布斯帕显效时间2周左右。
 
6.布斯帕不宜与中枢抑制药、降压药、抗凝药、避孕药及单胺氧化化酶抑制药(MAOI)合用。
 
【布斯帕BusPIRone 不良反应】
 
1.常见的不良反应有头晕、头痛、恶心、不安、烦躁。
 
2.少见的不良反应有视物不清、注意力涣散、萎靡、口干、肌肉痛、肌肉痉挛、抽动、肌强直、耳鸣、激动、失眠、神经过敏、腹泻、胃部不适、梦魇、多梦、疲乏无力。
 
3.罕见的不良反应有胸痛、精神错乱、抑郁、心动过速、肌无力、肌肉麻木、手足无力。

Bispar(BusPIRone)

 
Buspirone, sold under the brand name Buspar among others, is a medication primarily used to treat anxiety disorders particularly general anxiety disorder.[9][10] Benefits are support for short term use.[11] It is not useful for psychosis.[9] It is taken by mouth.[9] It may take up to four weeks for an effect.[10]
 
Common side effects include nausea, headaches, dizziness, and trouble concentrating.[9][11]Serious side effects may include hallucinations, serotonin syndrome, and seizures.[11] Use in pregnancy appears to be safe but has not been well studied, while use during breastfeedingis not recommended.[12][11] How it works is not clear but it is unrelated to benzodiazepines.[9]
Buspirone was first made in 1968 and approved for medical use in the United States in 1986.[9][10] It is avaliable as a generic medication.[11] A month supply in the United Kingdom costs the NHS about 10 £ as of 2019.[11] In the United States the wholesale cost of this amount is about 2.65 USD.[13] In 2016 it was the 90th most prescribed medication in the United States with more than 8 million prescriptions.[14]
 
 
Medical uses
Anxiety
Buspirone is used for the short-treatment of anxiety disorders or symptoms of anxiety.[15][16][17][18][19] It is generally less preferred than selective serotonin reuptake inhibitors (SSRIs).[10]
Buspirone has no immediate anxiolytic effects, and hence has a delayed onset of action; its full clinical effectiveness may require 2 to 4 weeks to manifest.[20] The drug has been shown to be similarly effective in the treatment of GAD to benzodiazepines including diazepam, alprazolam, lorazepam, and clorazepate.[4] Buspirone is not known to be effective in the treatment of other anxiety disorders besides GAD,[21] although there is some limited evidence that it may be useful in the treatment of social phobia as an adjunct to selective serotonin reuptake inhibitors (SSRIs).[4][22]
Sexual dysfunction
There is some evidence that buspirone on its own may be useful in the treatment of hypoactive sexual desire disorder (HSDD) in women.[23]
Miscellaneous
Buspirone is not effective as a treatment for benzodiazepine withdrawal, barbiturate withdrawal, or alcohol withdrawal/delirium tremens.[24]
 
Contraindications
 
Buspirone has these contraindications:[25][26]
 
§  Hypersensitivity to buspirone
 
§  Metabolic acidosis, as in diabetes
 
§  Should not be used with MAO inhibitors
 
§  Severely compromised liver and/or kidney function
 
Overdose
 
Buspirone appears to be relatively benign in cases of single-drug overdose, although no definitive data on this subject appear to be available.[27] In one clinical trial, buspirone was administered to healthy male volunteers at a dosage of 375 mg/day, and produced side effects including nausea, vomiting, dizziness, drowsiness, miosis, and gastric distress.[15][16][18] In early clinical trials, buspirone was given at dosages even as high as 2,400 mg/day, with akathisia, tremor, and muscle rigidity observed.[28] Deliberate overdoses with 250 mg and up to 300 mg buspirone have resulted in drowsiness in about 50% of individuals.[28] One death has been reported in association with 450 mg buspirone together with alprazolam, diltiazem, alcohol, cocaine.[28]
 
 




注:药品如有新包装,以新包装为准。以上资讯仅供医护人员内部讨论,不作任何用药依据,具体用药指引,请咨询主治医师。

更多相关资讯:返回顶部
最新药品资讯
  • Venclyxto(维奈妥拉)联合MabThera治疗慢淋白血病,患者死亡风险降低!
  • Tagrisso(Osimertinib)在英国获批用于两种肺癌适应症的治疗
  • ziritaxestat治疗弥漫性皮肤系统性硬化症(dcSSc)2期概念验证研究成功!
  • 美国FDA批准GSK三联疗法:可同时治疗哮喘和慢阻肺
  • NBIb-1817一次性治疗帕金森病(PD)显著改善运动功能、延长ON时间
  • 口服抗生素tebipenem HBr治疗cUTI和AP关键III期临床成功,疗效不劣于ertapenem
  • 下一代选择性免疫调节剂IMU-838治疗多发性硬化症(RRMS)具有显著疗效,有良好的安全性和耐受性!
  • Fintepla(芬氟拉明)口服溶液治疗Dravet综合征相关癫痫的第三项3期研究结果:抽搐发作显著减少
  • 视神经脊髓炎谱系障碍(NMOSD)创新药Enspryng(satralizumab)获美FDA批准
  • Fasenra与标准类固醇同时治疗鼻息肉三期临床结果积极
  • Darzalex Faspro申请新适应症,治疗轻链(AL)淀粉样变性!
  • 地诺单抗(Xgeva,denosumab)治疗实体瘤骨转移疗效怎样?
  • 新药IDH1抑制剂Tibsovo治疗胆管癌效果怎么样?
  • 拜耳Nubeqa(达罗他胺)治疗非转移性去势抵抗性前列腺癌显著延长患者生存!
  • FDA对罗氏Tecentriq治疗三阴性乳腺癌研究发出警告!
  • 加码多发性硬化症!罗氏启动三项临床试验研究
  • Xeglyze说明书-价格-功效与作用-副作用
  • 赛诺菲/再生元Dupixent(达必妥®)显著延缓哮喘患者肺功能下降:疗效维持3年!
  • 默沙东止咳药gefapixant2项关键III期临床试验成功:咳嗽频率显著降低
  • Ryplazim(纤溶酶原)再次申请上市:首个先天性纤溶酶原缺乏症(C-PLGD)治疗药物!
  • 拜耳Adempas用于经PDE5i治疗反应不足的肺动脉高压(PAH)患者IV期临床成功
  • Midostaurin(米哚妥林)适应症是什么?优势在哪里?
  • 艾普利Apixaban可以在哪里买到正品?
  • 维奈妥拉/维奈托克(VENETOCLAX)怎么服用?注意事项是什么?
  • 芦可替尼Ruxolitinib治疗特应性皮炎效果好不好?
  • 巯嘌呤片(6-MP)Puri-nethol治疗急性白血病效果如何?
  • 晚期HCC患者能从Ramucirumab中获益吗?
  • 赫赛汀+拉帕替尼治疗乳腺癌效果更好
  • 欧盟批准Imfinzi(英飞凡):一线治疗广泛期小细胞肺癌(ES-SCLC)!
  • 第三代强效COMT抑制剂Ongentys(opicapone)用于治疗帕金森病(PD)的新药在日本上市!


  • 如您发现本网站有文字编辑或内容错误,请点击此处发送(需要安装有foxmail或outlook支持),


    或发邮件至:info@morecare.hk,香港济民药业感谢您的到访!


    欢迎您添加香港济民药业微信,或在公众号内留言。

    香港济民微信公众号
    • 香港济民药业友情链接
    • 友情链接

    联系我们:

    地址:
    Rm. 314, Sun Ling Plaza, 30 On Kui Street, Fanling, HONG KONG
    邮箱:
    info@pidrug.com
    电话:
    198 9654 1773
    粤ICP备17150936号
    香港济民药业官方网站
    • 关注我们 :
    • 香港济民药业微博
    • 关注香港济民药业博客
    • 香港济民药业微信公众号